MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$51,148K
EPS
-$1.58
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Research and development expenses
39,054
General and administrative expenses
17,835
Total operating expenses
56,889
Loss from operations
-56,889
Interest income and other, net
5,851
Total other income
5,851
Net loss
-51,038
Net unrealized gain (loss) on marketable securities
-110
Total comprehensive loss
-51,148
Basic EPS
-1.58
Diluted EPS
-1.58
Basic Average Shares
32,345,525
Diluted Average Shares
32,345,525
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Total comprehensiveloss-$51,148K Interest income andother, net$5,851K Net loss-$51,038K Net unrealized gain(loss) on marketable...-$110K Total other income$5,851K Loss from operations-$56,889K Total operatingexpenses$56,889K Research and developmentexpenses$39,054K General andadministrative expenses$17,835K

Sagimet Biosciences Inc. (SGMT)

Sagimet Biosciences Inc. (SGMT)